Anne Wojcicki

human dna structure with glass helix destroyed

MedTech

23andMe shutters cancer drug research, lays off 40% of staff

The genetics testing company plans to seek out new homes for its in-house pipeline of DNA-informed immuno-oncology antibodies.

Conor Hale Nov 11, 2024 9:07pm

23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMine: Anne Wojcicki aims to take genetics company private

Apr 18, 2024 9:16am

data stream

Takeda, Anne Wojcicki back Seqster’s healthcare data platform

Apr 22, 2021 10:00am